| Title |
Inactivation of cancer-associated-fibroblasts (CAF) disrupts oncogenic signaling in pancreatic cancer cells and promotes its regression
|
|---|---|
| Published in |
Cancer Research, February 2018
|
| DOI | 10.1158/0008-5472.can-17-2320 |
| Pubmed ID | |
| Authors | |
| Abstract |
Resident fibroblasts that contact tumor epithelial cells (TEC) can become irreversibly activated as cancer-associated-fibroblasts (CAF) which stimulate oncogenic signaling in TEC. In this study, we evaluated the crosstalk between CAF and TEC isolated from tumors generated in a mouse model of KRAS/mutp53-induced pancreatic cancer (KPC mice). Transcriptomic profiling conducted after treatment with the anticancer compound Minnelide revealed deregulation of the TGF-β signaling pathway in CAF, resulting in an apparent reversal of their activated state to a quiescent, non-proliferative state. TEC exposed to media conditioned by drug-treated CAF exhibited a decrease in oncogenic signaling as manifested by downregulation of the transcription factor Sp1. This inhibition was rescued by treating TEC with TGF-β. Given promising early clinical studies with minnelide, our findings suggest that approaches to inactivate CAF and prevent tumor-stroma crosstalk may offer a viable strategy to treat pancreatic cancer. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 158 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 39 | 25% |
| Student > Bachelor | 22 | 14% |
| Researcher | 19 | 12% |
| Student > Master | 15 | 9% |
| Student > Doctoral Student | 8 | 5% |
| Other | 20 | 13% |
| Unknown | 35 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 53 | 34% |
| Medicine and Dentistry | 20 | 13% |
| Agricultural and Biological Sciences | 19 | 12% |
| Immunology and Microbiology | 7 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
| Other | 18 | 11% |
| Unknown | 35 | 22% |